We are live on ! Find out more
PVI

Pura Vida Investments Portfolio holdings

AUM $14.9M
1-Year Est. Return 38.76%
This Fund
S&P 500
This Quarter Est. Return
+43.29%
1 Year Est. Return
+38.76%
3 Year Est. Return
+26.8%
5 Year Est. Return
+25.03%
10 Year Est. Return
+1,723.84%
AUM
$2.75B
AUM Growth
+$811M
Cap. Flow
+$363M
Cap. Flow %
13.21%
Top 10 Hldgs %
44.65%
Holding
241
New
88
Increased
39
Reduced
33
Closed
64

Top Buys

Rank Stock Value
1
MDVL
MedAvail Holdings, Inc. Common Stock
MDVL
+$36.2M
2
HYFM icon
Hydrofarm Holdings
HYFM
+$19.6M
3
LUNG icon
Pulmonx
LUNG
+$19.2M
4
SEER icon
Seer Inc
SEER
+$18.7M
5
ABCL icon
AbCellera Biologics
ABCL
+$16.7M

Top Sells

Rank Stock Value
1
COO icon
Cooper Companies
COO
+$27M
2
INSP icon
Inspire Medical Systems
INSP
+$11.3M
3
PPD
PPD, Inc. Common Stock
PPD
+$11.1M
4
STAA icon
STAAR Surgical
STAA
+$10.4M
5
ALXN
Alexion Pharmaceuticals
ALXN
+$9.3M

Sector Composition

Rank Sector Weight
1 Healthcare 34.42%
2 Industrials 1.65%
3 Consumer Staples 0.32%
4 Financials 0.08%
5 Materials 0.08%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
AAL icon
176
CALL
American Airlines Group
AAL
$9.88B
– –
-373,800
Closed -$4.59M
AMGN icon
177
CALL
Amgen
AMGN
$225B
– –
-40,000
Closed -$10.2M
ARDX icon
178
Ardelyx
ARDX
$1.03B
– –
-418,908
Closed -$2.2M
ATRC icon
179
CALL
AtriCure
ATRC
$2.22B
– –
-75,000
Closed -$2.99M
AUPH icon
180
Aurinia Pharmaceuticals
AUPH
$2.06B
– –
-50,000
Closed -$737K
AVTR icon
181
Avantor
AVTR
$9.42B
– –
-105,000
Closed -$2.36M
BCRX icon
182
PUT
BioCryst Pharmaceuticals
BCRX
$2.71B
– –
-116,800
Closed -$401K
BMRN icon
183
BioMarin Pharmaceuticals
BMRN
$13.6B
– –
-10,000
Closed -$761K
BMY icon
184
CALL
Bristol-Myers Squibb
BMY
$130B
– –
-100,000
Closed -$6.03M
BMY icon
185
Bristol-Myers Squibb
BMY
$130B
– –
-87,469
Closed -$5.27M
BNR
186
Burning Rock Biotech
BNR
$105M
– –
-17,664
Closed -$4.43M
CLDX icon
187
Celldex Therapeutics
CLDX
$3.52B
– –
-144,200
Closed -$2.14M
CODX
188
PUT
Co-Diagnostics
CODX
$5.45M
– –
-1,667
Closed -$680K
COO icon
189
Cooper Companies
COO
$15B
– –
-320,000
Closed -$27M
CORT icon
190
CALL
Corcept Therapeutics
CORT
$12.1B
– –
-188,900
Closed -$3.29M
CRBP icon
191
Corbus Pharmaceuticals
CRBP
$189M
– –
-16,273
Closed -$879K
CRBP icon
192
PUT
Corbus Pharmaceuticals
CRBP
$189M
– –
-16,667
Closed -$900K
DIN icon
193
CALL
Dine Brands
DIN
$462M
– –
-50,000
Closed -$2.73M
EOLS icon
194
PUT
Evolus
EOLS
$536M
– –
-294,500
Closed -$1.15M
EW icon
195
PUT
Edwards Lifesciences
EW
$53.6B
– –
-50,000
Closed -$3.99M
EXAS
196
CALL
DELISTED
Exact Sciences
EXAS
– –
-40,000
Closed -$4.08M
GKOS icon
197
CALL
Glaukos
GKOS
$11B
– –
-100,000
Closed -$4.95M
HOLX
198
CALL
DELISTED
Hologic
HOLX
– –
-62,500
Closed -$4.15M
INCY icon
199
CALL
Incyte
INCY
$24.5B
– –
-30,000
Closed -$2.69M
INO icon
200
PUT
Inovio Pharmaceuticals
INO
$79.6M
– –
-10,858
Closed -$1.51M
6 7
8
9 10

Similar funds

BCA
Boundary Creek Advisors New York $15.3M AUM 0.41% 1-Year Est. Return
RC
Raine Capital New York $14.1M AUM 33.16% 1-Year Est. Return
DOFI
DCVC Opportunity Fund II Palo Alto, California $13.9M AUM 8.04% 1-Year Est. Return
SCI
SkyBridge Capital II New York $13.1M AUM 3.36% 1-Year Est. Return
LPC
Lion Point Capital New York $16.7M AUM 119.35% 1-Year Est. Return
GBCP
Glade Brook Capital Partners Greenwich, Connecticut $12.8M AUM
SCTC
Samsung C&T Corporation Seoul, South Korea $17.2M AUM 23.45% 1-Year Est. Return
M
MetLife New York $12.3M AUM 29% 1-Year Est. Return

Pura Vida Investments's Q4 2020 Portfolio in Review

As of Q4 2020, Pura Vida Investments held 241 positions worth $2.75B, up 42% from $1.94B the previous quarter. Its ten largest holdings account for 45% of the portfolio.

Pura Vida Investments deployed $363M of net new capital in Q4 2020, opening 88 new positions and adding to 39 existing holdings. Its largest new stake was MedAvail Holdings, Inc. Common Stock: 51,760 shares worth $36.9M.

By sector, the portfolio is most concentrated in Healthcare at 34% of assets, up from 32% a quarter earlier, followed by Industrials and Consumer Staples.

On the sell side, the largest reduction was Inspire Medical Systems, an estimated $11.3M trimmed.

  • Pura Vida Investments's largest Q4 2020 buy was MedAvail Holdings, Inc. Common Stock: 51,760 shares worth $36.9M.
  • Pura Vida Investments added most to Guardant Health in Q4 2020, an estimated $9.2M increase.
  • Pura Vida Investments's biggest Q4 2020 reduction was Inspire Medical Systems, cutting an estimated $11.3M.
  • Pura Vida Investments fully exited Cooper Companies in Q4 2020, selling an estimated $27M.
  • Pura Vida Investments's ten largest holdings make up 45% of its $2.75B portfolio in Q4 2020.
  • Pura Vida Investments opened 88 new positions and closed 64 in Q4 2020.
  • Pura Vida Investments's portfolio value rose 42% quarter-over-quarter to $2.75B.

Based on Pura Vida Investments's 13F filing for Q4 2020, filed 16 Feb 2021.